Moving forward, rather than the traditional sledghammer knockout approach, targeted phosphorylation knock-in mouse models of known AMPK substrates will be the only way to specifically interrogate the mechanism(s) by which AMPK-regulated pathways like autophagy and lipid metabolism affect atherosclerosis and other cardiometabolic diseases. This evidence concerns the gene PRKAA1 and atherosclerosis.